Activated Allogeneic NK Cells as Suppressors of Alloreactive Responses

Bo Hu, Yan He, Yan Wu, Guangming Bao, Haiyan Liu, Lisbeth A. Welniak, William J Murphy

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Donor NK cells have been shown to be able to promote engraftment during allogeneic bone marrow transplantation. They could specifically suppress or delete host reactive cells, thereby facilitating engraftment of donor marrow. To further elucidate the mechanism, we showed that activated H2d ALAK cells (adherent lymphokine activated killer, IL-2 activated T cell-depleted bone marrow and spleen cells) from BALB/c mice significantly suppressed the proliferation of H2b splenocytes from C57BL/6 mice in mixed lymphocyte responses (MLR) stimulated with irradiated H2d splenocytes from BALB/c mice (P < .01). The ability for H2b splenocytes to kill H2d tumor targets was also significantly inhibited by activated H2d ALAK cells (P < .01). The same number of H2b ALAK cells or H2d splenocytes did not show the same suppressive effect. These results suggested that activated H2d ALAK cells could specifically suppress the anti-H2d activity of the H2b splenocytes. Anti-tumor growth factor (TGF)β antibody blockade did not diminish this suppressive effect of ALAK cells, suggesting that this activity is not dependent on TGF-β secretion. ALAKs from gld (FasL mutant) mice suppressed the allo-responses as well as the wild-type ALAK cells. The ALAKs from pfp (perforin knockout) mice did not completely block the inhibitory effect, which suggested that the suppressive effect of the allogeneic ALAK cells could be partially caused by perforin-mediated killing. We further demonstrated that donor ALAK cells could promote engraftment by suppressing host alloreactive responses in a nonmyeloablative allogeneic BMT model. These studies suggest that activated donor NK cells specifically suppress the alloreactive cells and provide a promising way to promote donor engraftment without involving systemic and nonspecific suppression of the immune system.

Original languageEnglish (US)
Pages (from-to)772-781
Number of pages10
JournalBiology of Blood and Marrow Transplantation
Volume16
Issue number6
DOIs
StatePublished - Jun 2010
Externally publishedYes

Fingerprint

Natural Killer Cells
Perforin
Intercellular Signaling Peptides and Proteins
Lymphokine-Activated Killer Cells
Neoplasms
Homologous Transplantation
Bone Marrow Transplantation
Inbred C57BL Mouse
Knockout Mice
Bone Marrow Cells
Interleukin-2
Immune System
Spleen
Bone Marrow
Lymphocytes
T-Lymphocytes
Antibodies

Keywords

  • Allogeneic BMT
  • Mixed lymphocyte responses
  • Natural killer cells

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Activated Allogeneic NK Cells as Suppressors of Alloreactive Responses. / Hu, Bo; He, Yan; Wu, Yan; Bao, Guangming; Liu, Haiyan; Welniak, Lisbeth A.; Murphy, William J.

In: Biology of Blood and Marrow Transplantation, Vol. 16, No. 6, 06.2010, p. 772-781.

Research output: Contribution to journalArticle

Hu, Bo ; He, Yan ; Wu, Yan ; Bao, Guangming ; Liu, Haiyan ; Welniak, Lisbeth A. ; Murphy, William J. / Activated Allogeneic NK Cells as Suppressors of Alloreactive Responses. In: Biology of Blood and Marrow Transplantation. 2010 ; Vol. 16, No. 6. pp. 772-781.
@article{f0e93a1f28a043b085b2ec295a0c1395,
title = "Activated Allogeneic NK Cells as Suppressors of Alloreactive Responses",
abstract = "Donor NK cells have been shown to be able to promote engraftment during allogeneic bone marrow transplantation. They could specifically suppress or delete host reactive cells, thereby facilitating engraftment of donor marrow. To further elucidate the mechanism, we showed that activated H2d ALAK cells (adherent lymphokine activated killer, IL-2 activated T cell-depleted bone marrow and spleen cells) from BALB/c mice significantly suppressed the proliferation of H2b splenocytes from C57BL/6 mice in mixed lymphocyte responses (MLR) stimulated with irradiated H2d splenocytes from BALB/c mice (P < .01). The ability for H2b splenocytes to kill H2d tumor targets was also significantly inhibited by activated H2d ALAK cells (P < .01). The same number of H2b ALAK cells or H2d splenocytes did not show the same suppressive effect. These results suggested that activated H2d ALAK cells could specifically suppress the anti-H2d activity of the H2b splenocytes. Anti-tumor growth factor (TGF)β antibody blockade did not diminish this suppressive effect of ALAK cells, suggesting that this activity is not dependent on TGF-β secretion. ALAKs from gld (FasL mutant) mice suppressed the allo-responses as well as the wild-type ALAK cells. The ALAKs from pfp (perforin knockout) mice did not completely block the inhibitory effect, which suggested that the suppressive effect of the allogeneic ALAK cells could be partially caused by perforin-mediated killing. We further demonstrated that donor ALAK cells could promote engraftment by suppressing host alloreactive responses in a nonmyeloablative allogeneic BMT model. These studies suggest that activated donor NK cells specifically suppress the alloreactive cells and provide a promising way to promote donor engraftment without involving systemic and nonspecific suppression of the immune system.",
keywords = "Allogeneic BMT, Mixed lymphocyte responses, Natural killer cells",
author = "Bo Hu and Yan He and Yan Wu and Guangming Bao and Haiyan Liu and Welniak, {Lisbeth A.} and Murphy, {William J}",
year = "2010",
month = "6",
doi = "10.1016/j.bbmt.2010.02.023",
language = "English (US)",
volume = "16",
pages = "772--781",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Activated Allogeneic NK Cells as Suppressors of Alloreactive Responses

AU - Hu, Bo

AU - He, Yan

AU - Wu, Yan

AU - Bao, Guangming

AU - Liu, Haiyan

AU - Welniak, Lisbeth A.

AU - Murphy, William J

PY - 2010/6

Y1 - 2010/6

N2 - Donor NK cells have been shown to be able to promote engraftment during allogeneic bone marrow transplantation. They could specifically suppress or delete host reactive cells, thereby facilitating engraftment of donor marrow. To further elucidate the mechanism, we showed that activated H2d ALAK cells (adherent lymphokine activated killer, IL-2 activated T cell-depleted bone marrow and spleen cells) from BALB/c mice significantly suppressed the proliferation of H2b splenocytes from C57BL/6 mice in mixed lymphocyte responses (MLR) stimulated with irradiated H2d splenocytes from BALB/c mice (P < .01). The ability for H2b splenocytes to kill H2d tumor targets was also significantly inhibited by activated H2d ALAK cells (P < .01). The same number of H2b ALAK cells or H2d splenocytes did not show the same suppressive effect. These results suggested that activated H2d ALAK cells could specifically suppress the anti-H2d activity of the H2b splenocytes. Anti-tumor growth factor (TGF)β antibody blockade did not diminish this suppressive effect of ALAK cells, suggesting that this activity is not dependent on TGF-β secretion. ALAKs from gld (FasL mutant) mice suppressed the allo-responses as well as the wild-type ALAK cells. The ALAKs from pfp (perforin knockout) mice did not completely block the inhibitory effect, which suggested that the suppressive effect of the allogeneic ALAK cells could be partially caused by perforin-mediated killing. We further demonstrated that donor ALAK cells could promote engraftment by suppressing host alloreactive responses in a nonmyeloablative allogeneic BMT model. These studies suggest that activated donor NK cells specifically suppress the alloreactive cells and provide a promising way to promote donor engraftment without involving systemic and nonspecific suppression of the immune system.

AB - Donor NK cells have been shown to be able to promote engraftment during allogeneic bone marrow transplantation. They could specifically suppress or delete host reactive cells, thereby facilitating engraftment of donor marrow. To further elucidate the mechanism, we showed that activated H2d ALAK cells (adherent lymphokine activated killer, IL-2 activated T cell-depleted bone marrow and spleen cells) from BALB/c mice significantly suppressed the proliferation of H2b splenocytes from C57BL/6 mice in mixed lymphocyte responses (MLR) stimulated with irradiated H2d splenocytes from BALB/c mice (P < .01). The ability for H2b splenocytes to kill H2d tumor targets was also significantly inhibited by activated H2d ALAK cells (P < .01). The same number of H2b ALAK cells or H2d splenocytes did not show the same suppressive effect. These results suggested that activated H2d ALAK cells could specifically suppress the anti-H2d activity of the H2b splenocytes. Anti-tumor growth factor (TGF)β antibody blockade did not diminish this suppressive effect of ALAK cells, suggesting that this activity is not dependent on TGF-β secretion. ALAKs from gld (FasL mutant) mice suppressed the allo-responses as well as the wild-type ALAK cells. The ALAKs from pfp (perforin knockout) mice did not completely block the inhibitory effect, which suggested that the suppressive effect of the allogeneic ALAK cells could be partially caused by perforin-mediated killing. We further demonstrated that donor ALAK cells could promote engraftment by suppressing host alloreactive responses in a nonmyeloablative allogeneic BMT model. These studies suggest that activated donor NK cells specifically suppress the alloreactive cells and provide a promising way to promote donor engraftment without involving systemic and nonspecific suppression of the immune system.

KW - Allogeneic BMT

KW - Mixed lymphocyte responses

KW - Natural killer cells

UR - http://www.scopus.com/inward/record.url?scp=77952585702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952585702&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2010.02.023

DO - 10.1016/j.bbmt.2010.02.023

M3 - Article

C2 - 20197103

AN - SCOPUS:77952585702

VL - 16

SP - 772

EP - 781

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 6

ER -